insights_auto
Why is MBIO down 2,44%?
Dive Deeperchevron_right
MBIO:NASDAQ
Mustang Bio Inc
US$0,40
arrow_downward
-2,44%(-0,010) 1D
US$0,40
arrow_upward
+1,15% (+0,0046)bedtimeAfter hours
Closed: 9 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Open
US$0,43
High
US$0,43
Low
US$0,38
Mkt. cap
3,01 ລ້ານ
Avg. vol.
29,09 ພັນ
Volume
99,18 ພັນ
52-wk high
US$1,80
52-wk low
US$0,38
EPS
US$-0,46
Beta
2,09
Shares outstanding
6,73 ລ້ານ
No. of employees
4
Open
US$0,43
High
US$0,43
Low
US$0,38
Mkt. cap
3,01 ລ້ານ
Avg. vol.
29,09 ພັນ
Volume
99,18 ພັນ
52-wk high
US$1,80
52-wk low
US$0,38
EPS
US$-0,46
Beta
2,09
Shares outstanding
6,73 ລ້ານ
No. of employees
4
News stories
From web sources and news partners
The Globe and Mail
·
19 ນາທີກ່ອນ
Kaplan Fox Reminds Investors of Duolingo, Inc. (NASDAQ: DUOL) to a Securities Class Action Deadline - Contact the Firm Before December 7, 2026
Simply Wall Street
·
20 ນາທີກ່ອນ
Shopify (SHOP) Stock May Trade At A Premium Following Canvas Launch
Mitrade
·
25 ນາທີກ່ອນ
Current S&P 500 Bull Market Turns 4 Monday and History Suggests More to Come
Nasdaq
·
13 ຊົ່ວໂມງກ່ອນ
WISeSat.Space Holdings Corp. Rings the Opening Bell
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersWaltham, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorBiotechnology
Websitemustangbio.com